Lafayette, CA, United States of America

Robert Arslanian

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Arslanian. Retrieved from https://idiyas.com/inventor/robert-arslanian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Arslanian

Introduction

Robert Arslanian is a notable inventor based in Lafayette, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his work on novel compounds and formulations. His innovative spirit and dedication to research have led to the development of important medical advancements.

Latest Patents

One of Robert Arslanian's key patents is titled "17-allylamino-17-demethoxygeldanamycin polymorphs and formulations." This patent focuses on polymorphs and pharmaceutical formulations of 17-allylamino-17-demethoxygeldanamycin (17-AAG). His work in this area has the potential to impact cancer treatment significantly. He holds 1 patent in total.

Career Highlights

Robert Arslanian is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role there allows him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.

Collaborations

Throughout his career, Robert has worked alongside esteemed colleagues such as Jorge L. Galazzo and Greg O. Buchanan. These collaborations have fostered an environment of innovation and creativity, leading to advancements in pharmaceutical formulations.

Conclusion

Robert Arslanian's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors on medical science. His work continues to inspire future innovations in drug development and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…